Certara, Inc. Announces Expansion of Clinical Technology Collaboration with Merck

Published: 2025-07-08 09:20:34 ET CERT

Published on 07/08/2025 at 09:20

Certara, Inc. announced a new collaboration with Merck that expands Merck's use of the Certara Pinnacle 21 software platform to include a metadata repository and data standards workflow management. This agreement builds upon Merck's existing technology collaboration with Certara to aid in regulatory submissions. Reducing the time from data collection to validated, analysis-ready datasets has become more complex across drug development.

Phase III clinical trials now average 3.6 million datapoints, a threefold increase over the last decade. The Certara Pinnacle 21 platform is designed to solve the data standardization challenges of modern digital trials at scale.